Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Chapter 42 Sickle Cell Disease
- Chapter 43 Transfusions
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Chapter 42 - Sickle Cell Disease
from Subpart IVF - Clinical – Hematologic
Published online by Cambridge University Press: 31 March 2017
Edited by
Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Chapter 42 Sickle Cell Disease
- Chapter 43 Transfusions
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Observation MedicinePrinciples and Protocols, pp. 244 - 249Publisher: Cambridge University PressPrint publication year: 2017
References
Shapiro, B. Benjamin, LJ, Payne, R, Heidrich, G. Sickle cell-related pain: Perceptions of medical practitioners. J Pain Symptom Manage 1997;14(3):168–174.CrossRefGoogle ScholarPubMed
Conran, N, Franco-Penteado, CF, Costa, FF. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin. 2009;33(1):1–16.CrossRefGoogle ScholarPubMed
Rupp, T, Delaney, K. Inadequate analgesia in emergency medicine. Annals of Emergency Medicine. 2004;43(4):494–503.CrossRefGoogle ScholarPubMed
Brookoff, D, Polomano, R. Treating sickle cell pain like cancer pain. Annals of Internal Medicine. 1992;116(5):364–368.CrossRefGoogle ScholarPubMed
Roseff, SD, Sickle cell disease: a review. Immunohematology/American Red Cross. 2009;25(2):67–74.Google ScholarPubMed
McClish, D, Smith, WR, Dahman, BA, et al. Pain site frequency and location in sickle cell disease: the PiSCES project. Pain. 2009:145(1–2):246–251.CrossRefGoogle ScholarPubMed
Platt, O, Thorington, BD, Brambilla, DJ, et al. Pain in sickle cell disease – rates and risk factors. NEJM. 1991;325:11–16.CrossRefGoogle ScholarPubMed
Ballas, SK, Gupta, K, Adams-Graves, P. Sickle cell pain: A critical reappraisal. Blood. 2012;120(18):3647–3656.CrossRefGoogle Scholar
Taylor, LEV, Scotts, NA, Jumphreys, J, et al. A review of the literature on multiple dimensions of chronic pain in adults with sickle cell disease. Journal of Pain and Symptom Management. 2010;40(3): 416–435.CrossRefGoogle ScholarPubMed
Drookoff, D, Polomano, R. Treating sickle cell pain like cancer pain. Annals of Internal Medicine. 1992;116(5):364–368.CrossRefGoogle Scholar
Waldrop, R, Mandry, C. Health professional perceptions of opioid dependence among patients with pain. American Journal of Emergency Medicine. 1995;13(5):529–531.CrossRefGoogle ScholarPubMed
Smith, WR, Jordan, LB, Hassel, KL. Frequently asked questions by hospitalist managing pain in adults with sickle cell disease. Journal of Hospital Medicine. 2011; 6:297–303.CrossRefGoogle ScholarPubMed
Yawn, BP, Buchanan, GR, Afenyi-Annan, AN, et al. Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–1048.CrossRefGoogle Scholar
Ballas, SK. The sickle cell painful crisis in adults: phases and objective signs. Hemoglobin. 1995;19(6) 323–333.CrossRefGoogle ScholarPubMed
Haywood, C, Beach, MC, Lanzkron, S, et al. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. Journal of the National Medical Association. 2009;101(10):1022–1033.CrossRefGoogle ScholarPubMed
Labbe, E, Herbert, D, Haynes, J. Physician’s attitude and practices in sickle cell disease pain management. J Palliative Care. 2005;21:246–251.CrossRefGoogle ScholarPubMed
Friedman, EW, Webber, AB, Osborn, HH, et al. Oral analgesia for treatment of painful crisis in sickle cell anemia. Ann Emergency Medicine. 1986;15:783–791.CrossRefGoogle ScholarPubMed
Silbergleit, R, Jancis, MO, McNamara, RM. Mangement of sickle cell pain crisis in the emergency department at teaching hospitals. Journal of Emergency Medicine. 1999;17(4):625–630.CrossRefGoogle Scholar
Benjamin, LJ, Dampier, CD, Jacox, AK, et al. Guidelines for the management of acute and chronic pain in sickle-cell disease. APS Clinical Practice Guideline Series, No. 1, 1999.Google Scholar
Solomon, LR. Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void. Blood 2008; 111:997–1003.CrossRefGoogle ScholarPubMed
Evidence-Based Management of Sickle Cell Disease: Expert Panel Report. 2014; Available from: https://www.nhlbi.nih.gov/health-pro/guidelines/sickle-cell-disease-guidelines.Google Scholar
Melzer-Lange, MD, Walsh-Kelly, C, Lea, G, et al. Patient-controlled analgesia for sickle cell pain crisis in a pediatric emergency department. 2004;20(2):2–4.Google Scholar
Rees, DC, Olujohungbe, AD, Parker, NE, et al. Guidelines for the management of the acute painful crisis in sickle cell disease. British Journal of Hematology. 2003;120(5):744–752.CrossRefGoogle ScholarPubMed
Lyon, M, Sinclair, D, Renwick, E. Comparison of outcomes before and after implementation of an observation unit clinical pathway for sickle cell vaso-occlusive crisis. Florida Journal of Sickle Cell Disease and Hemoglobinopahty. 2010. 4(1):19.Google Scholar